Emergent BioSolutions (EBS) PT Lowered to $5.50 at Singular Research

January 16, 2024 2:35 PM EST
Get Alerts EBS Hot Sheet
Price: $2.04 -0.97%

Rating Summary:
    10 Buy, 5 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 12 | New: 46
Join SI Premium – FREE
Singular Research analyst Frank DiLorenzo lowered the price target on Emergent BioSolutions (NYSE: EBS) to $5.50 (from $7.00) while maintaining a Buy-Long Term rating.

You May Also Be Interested In

Related Categories

Analyst PT Change